|
|
Many initially promising biotherapeutic candidates fail due to lack of efficacy or safety, but there are also candidates that fail due to stability, aggregation, and other issues related to cell line or process issues. Prepare for a successful transition to bring your drug candidate from discovery to the clinic.
|